Search
Panax notoginseng root
go.drugbank.com/drugs/DB14304InvestigationalIt is not an approved drug.
Synonyms: Notoginseng Radix Et RhizomaOndansetron Predicted Metabolism Pathway
smpdb.ca/view/SMP0174690MetabolicMetabolites of Ondansetron are predicted with biotransformer.
Ondansetron Serotonin antagonist Action Pathway
smpdb.ca/view/SMP0126768Drug actionThe peripheral actions of ondansetron are thought to be the predominant mechanism for its antiemetic effects. … Ondansetron also has effects peripherally by acting on the vagus nerve. It works on the 5-HT3 receptors that can be found at the vagus nerve terminals.
Rehmannia glutinosa root
go.drugbank.com/drugs/DB14290InvestigationalIt is not an approved drug.
Synonyms: Rehmanniae Preparata Radix Et EhizomaTurmeric
go.drugbank.com/drugs/DB14276ApprovedInvestigationalIt is not an approved drug.
Synonyms: Curcumarum Tuber Et Radix (Curcuma Longa)Methylprednisolone
go.drugbank.com/drugs/DB00959ApprovedInvestigationalVet approved[A188811] It was first described in the literature in the late 1950s.[A188811,A188814] Methylprednisolone was granted FDA approval on 24 October 1957.
Mixtures: Physicians EZ Use M-pred, Physicians EZ Use M-predProducts: METILPREDNISOLONE EG, URBASON 8MGRopinirole
go.drugbank.com/drugs/DB00268ApprovedInvestigationalIn 2005, it was the first drug approved in the US for the management of primary moderate to severe restless legs syndrome [A174547]. … It is manufactured by GlaxoSmithKline Pharmaceuticals. Ropinirole was initially approved in 1997 by the FDA [FDA label] for the management of Parkinson's disease.
Products: ROPINIROL - CT 8MG RET TAB, REQUIP MODUTAB 8MG RETBromhexine
go.drugbank.com/drugs/DB09019ApprovedInvestigationalIt was introduced into the market in 1963, and is widely available as an over-the-counter drug in many countries. … It is derived from the Adhatoda vasica plant and aids in the clearance of excess mucus, improving breathing and reducing cough.
Mixtures: PENBRITIN EX, GRIPOFEN-T®Products: AXINE SYRUP 4MG/5ML, VASICAN SYRUP 4MG/5MLSilodosin
go.drugbank.com/drugs/DB06207ApprovedInvestigationalIt is indicated for the symptomatic treatment of benign prostatic hyperplasia in adults. … [A231159] Silodosin was first approved by the FDA in October 2008 [A231159] and it is also approved in Europe and Canada.
Products: SILODOSINA EG, SILBESAN 8MG HKPFluvastatin
go.drugbank.com/drugs/DB01095ApprovedInvestigationalIt is also the first entirely synthetic HMG-CoA reductase inhibitor and is structurally distinct from the fungal derivatives of this therapeutic class. … HMG-CoA reductase catalyzes the conversion of HMG-CoA to mevalonic acid, the rate-limiting step in cholesterol biosynthesis.
Products: FLUVASTATIN - CT 80MG RET, FLUVASTATIN - CT 40MG HART